Induction of cognate and non-cognate t-cell help for b-cell ige production in relation to cd40 ligand expression

International Archives of Allergy and Immunology

Volumn 111, Issue 4, 1996, Pages 376-384

  Armerding, Dieter ^a   Hren, Andrea ^a   Callard, Robin E ^a   Man Fu, Shu ^a   Mudde, Geert C ^a  

^a Sandoz Research Institute   (Australia)

Author keywords

CD40; CD40 ligand; Cognate non cognate T B cell; Hyper IgM; IgE induction; Interaction; Superantigen; T cell help

Indexed keywords

CD2 ANTIGEN; CD3 ANTIGEN; CD40 ANTIGEN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN M; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 4; PHORBOL 13 ACETATE 12 MYRISTATE; SUPERANTIGEN;

ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; HELPER CELL; HUMAN; HUMAN CELL; HYPERIMMUNOGLOBULINEMIA; IMMUNOGLOBULIN PRODUCTION; PRIORITY JOURNAL; STAPHYLOCOCCUS; T LYMPHOCYTE; TONSIL; X CHROMOSOME LINKAGE;

EID: 0029796215     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000237396     Document Type: Article

References (39)

1. llollcnbaugh D, Ochs HD, Noelle J, Ledbetter JA, ArutTo A: The role ofCD40 and ¡is ligand in the regulation of the immune response, Immunol Rev 1994;138:23-37.
2. Fulcihan R, Ramcsh N, Geha R: Role of CD40-CD40-ligand interaction in Ig-isotypc switching, CurrOpin Immunol 1994:5:963-967.
3. Banchereau J, Bazan F, Sacland S, ct al: The CD40 antigen and its ligand, Ann Rev Immunol 1994:12:881-888.
4. Callard RE, Armitage RJ, Fanslow WC, Spriggs MK: CD40 ligand and its role in X-linked hyp-er-IgM syndrome, Immunol Today 1993:14: 559-564.
5. Aruffo A, Farrington M, Ilollenbough D, Li X, Milatovich A, Nonoyama S, Bajorath J, Gros-mair LS, Stenkamp R, Neubauer M, Roberts RL, Noelle RJ, Ledbetter JA, Francke U, Ochs HD: The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome, Cell 1993:72:291-300.
6. Krocjck RA, Graf D, Brugnoni D, Gilliani S, Korthauscr U, Ugazi A, Scnger G, Mages HW, Villa A, Notarangelo LD: Defective expression of CD40 ligand on T cells causes X-linked immunodeficiency with hyper-IgM (IIIGM-I), Immunol Rev 1994;138:39-57.
7. Allen RC, Armitage RJ, Conley ME, Rosenblatt H, Edelhoff S, Distcchc CM, Simoneaux DK, Fanslow WC, Belmont J, Spriggs MK: CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome, Science 1993:259:990-993.
8. Ramesh N, Futcihan R, Geha R: Molecular pathology of X-linked immunoglobulin deficiency with normal or elevated IgM (HIGMX-I), Immunol Rev 1994:138:87-104.
9. Stohl W, Crow MK: Inhibition by anti-C'D2 monoclonal antibodies of anti-CD3-induced T cell-dependent B cell activation, Cell Immunol 1990:130:257-270.
10. Avcrsa G, Punnonen J, de Vries JE: The 26-kD transmembrane form of tumor necrosis factor-a on activated CD4+ T cell clones provides a co-stimulatory- signal for human B cell activation, J Exp Med 1993;177:1575-1585.
11. Henehoz S, Gauchat JF, Aubry JP, Graber P, Ro-chon S, Bonncfoy Y: Stimulation of human IgE production by a subset of anti-C'D21 monoclonal antibodies: requirement of a co-signal to modulate r transcripts, Immunology 1994:81: 285-290.
12. Klaus SJ, Pinchuk LM, Ochs HD, Law CL, Fan-slow WC, Armitage RJ, Clark EA: Costimulation through CD28 enhances T cell-dependent B cell activation via CD40-CD40L interaction, J Immunol 1994:152:5643-5652.
13. Stohl W, Elliot JE, Linsley PS: Human T cell-dependent B cell differcntion induced by staphylococcal superantigens, J Immunol 1994: 153:117-127.
14. Nishioka Y, Lipsky PE: The role of CD40-CD40 Ligand interaction in human T cell-B cell collaboration, J Immunol 1994:153:1027-1036.
15. Kwckkcboom J, de Rijk D, Kasran A, Barcy A, de Groot C, der Boer M: Helper effector function on human T cells stimulated by anti-CTO mAh can be enhanced by co-stimulatory signals and is partially dependent on CD40-CD40 ligand interaction, Eur J Immunol 1994: 24:508-517.
16. Macchia D, Almerigogna P, Parronchi P, Ravina A, Vlaggi E, Romagnani S: Membrane tumour necrosis factor-a involved in the polyclonal B-ccll activation induced by HIV-infected human T cells, Nature 1994:363:464-466.
17. Diaz-Sanchez D, Chegini S, Zhang K, Saxon A: C'D58 (LFA-3) stimulation provides a singal for human isotype switching and IgE production distinct from CD40, J Immunol 1994:153:10 20.
18. Life P, Gauchat JG, Schnuriger V, Estoppey S, Mazzci G, Durandy A, Fischer A, Bonncfoy JY: T cell clones from X-linked hyper-immunoglobulin (IgM) patients induce IgE synthesis in vitro despite expression of nonfunctional CD40 ligand, J Exp Med 1994:180:1775-1784.
19. Armerding D, van Reijsen I-C, llrcn A, Mudde CG: Induction of IgE and IgG I in human B cell cultures with Staphylococcal superantigens: Role of helper T cell interaction, resistance to IFN-y, Immunoblot 1993:188:259-273.
20. Gruber MF, Bjorndahl JM, Nakamura S, Fu MS: Anti-CD45 inhibition of human B cell proliferation depends on the nature of activation signals and the state of B cell activation, J Immunol 1989:141:4144-4152.
21. Linsley PS, Brady W, Ledbetter JA: Binding of the B cell activation antigen B7 to CD28 cos-timulates T cell proliferation and IL-2mRNA accumulation, J Exp Med 1991;173:721-726.
22. Van Reijsen FC, Bruinzeel-Koomen CAFM, Kalthoff FS, Maggi R, Romagnani S, Westland JKT, Mudde CG, et al: Skin-derived aeroaller-gen-specific T-ccll clones of the TH2 phenotype in patients with atopic dermatitis, J Allergy Clin Immunol 1992:90:184-193.
23. Callard RE: Human B cell responses to cytokines; in Baldwin F (ed): Cytokines: A Practical Approach, London Oxford University Press, 1991, pp 121-125.
24. Callard RE, Smith SI I, Armitage RJ: CD40 ligand (CD40L) expression and Bcell function in agammaglobulinemia with normal or elevated levels of IgM (HIM), J Immunol 1994:153: 3295-3306.
25. C'hatila T, Scholl P, Spcrtini F, Ramesh N, Trcdc N, Fuleihan R, Geha RS, et al: Toxic shock syndrome toxin-1, toxic shock, and the immune system, Curr Top Microbiol Immunol 1991; 174:62-79.
26. Mourad W, Scholl P, Diaz A, Geha R, Chatila T: The staphylococcal toxic shock syndrome toxin I triggers B cell proliferation and differentiation via major histocompatibility complex unrestricted cognate T/B interaction, J Exp Med 1989:170:2011-2022.
27. Fleischer B: The human Tcell response to mito-gcnic microbial cxotoxins, Curr Top Microbiol Immunol 1991:174:53-62.
28. Noelle RJ, McCann J, Marshall L, Bartlett WC: Cognate Interactions between helpcrT cells and Bcells, III.Contact-dependent, lymphokinc-in-dependent induction of B cell cycle entry by activated helper T cells, J Immunol 1989:143: 1807-1814.
29. Brines RD, Klaus GB: Polyclonal activation of immature B cells by preactivated T cells, The role of IL-4 and CD40 ligand, Int Immunol 1993:11:1445-1450.
30. Castle BE: Kishimoto K, Stearns C, Brown ML, Kehry MR: Regulation of expression of the ligand for CD40 on T helper lymphocytes, J Immunol 1993:151:1777-1788.
31. Patel SS, Thiele D, Lipsky P: Stimulus-dependent modulation of human B cell function by T cell clones, Cell Immunol 1993;146:362-381.
32. Spriggs MK, Armitage RJ, Strockbinc L, Clifford KN, MacDuff BM, Sato TA, Maliszcwski CR, Fanslow WC: Recombinant human CD40 ligand stimulates B cell proliferation and immunoglobulin E secretion, J Exp Med 1992:176: 1543-1550.
33. Roy M, Waldschmidt T, Aruffo A, Ledbetter JA, Nocllc RJ: The regulation of the expression of gp39, the CD40 ligand, on normal and cloned CD4+ T cells, J Immunol 1993:151:2497-2510.
34. Gauchat JF, Aubry JP, Mazzei G, Life P, Jomottc T, Elson G, Bonnefoy J Y: Human CD40-ligand: molecular cloning, cellular distribution and regulation of expression by factors controlling IgE production, FEBS Lett 1993:315:259-265.
35. Kawabe T, Naka T, Tanaka T, Fujivvara H, Suc-matsu S, Yoshida N, Kishimoto T, Kikutani H: The immune responses in CD40-dcficicnt mice: Impaired immunoglobulin class switching and germinal center formation, Immunity 1994:1:167-178.
36. Renshaw UR, Fanslow HWC, Armitage RJ, Campbell KA, Liggitt D, Wright B, Davison BL, Maliszcwski CR: Humoral immune responses in CD40 ligand-dcficient mice, J Exp Med 1994;180:1889-1900.
37. Xu J, Foy IM, Laman JD, Elliott EA, Wald-schmidt TJ, Elsemore J, Noelle RJ, Flavell RA: Mice deficient for the CD40 ligand, Immunity 1994;1:423-431.
38. Foy TM, Laman JD, Ledbetter JA, Aruffo A, C'laassen E, Noelle RJ: gp39-CD40 interactions are essential for germinal center formation and the development of B cell memory, J Exp Med 1994:180:157-163.
39. Grammar AC, Bergman MC, Miura Y, Fujita K, Davis LS, Lipsky PE: The CD40 ligand expressed by human B cells costimulatcs B cell responses, J Immunol 1995;154:4996-5010.